A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma
Titel:
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma
Auteur:
Padrnos, Leslie Ernst, Brenda Dueck, Amylou C. Kosiorek, Heidi E. Ginos, Brenda F. Toro, Angela Johnston, Patrick B. Habermann, Thomas M. Leis, Jose F. Mikhael, Joseph R. Nowakowski, Grzegorz S. Colgan, Joseph Porrata, Luis Ansell, Stephen M. Witzig, Thomas E. Reeder, Craig